lol @ HA. It's so obvious that the bashers can't really do anything here. Lot's of shares in strong hands. Sure there may be dilution, but I haven't seen anything other than an OTC play with potential. Would like to hear something from Management though. Starting to think they are either trying to do things the right way or are like a lot of the other cannabis rockets right now that aren't in any way justifiable.
News 
Market Data 
Discover 
AI
